drugset
drugset / Trial / NCT01382199

Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients

NCT01382199 ↗

Phase 3 Unknown 340 enrolled Ventria Bioscience National Institute on Aging (NIA) · collab
RandomizedDouble-blindPrevention

Summary

The purpose of the study is to Evaluate the Efficacy and Safety of Recombinant Human Lactoferrin Administered Orally for the Prevention of Antibiotic Associated Diarrhea in Adult Patients.

Timeline

Start
2011-09
Primary completion
2013-09
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Lactoferrin Protein / enzyme biologic — Oral

Indications

diarrheal disease